Found vs. Hims & Hers: prices, fine print, and the honest verdict

Tirzepatide pricing

Found: $289 a month all-in at the 10 mg maintenance basis, flat at every dose from 2.5 to 15 mg, no membership fee. Prepaid terms bring the effective rate to $169/mo (12-month plan paid up front). Hims & Hers offers tirzepatide without a published price we could capture.

Semaglutide pricing

Only Found publishes a semaglutide price here: Semaglutide runs $289 a month all-in at the standing rate ($169 on intro/plan terms). Hims & Hers offers semaglutide without a published price.

Different products, not just different prices

Hims & Hers fulfills the FDA-approved product — reviewed manufacturing, verified identity and sterility, stable legal status — while Found sells compounded medication: pharmacy-prepared, not FDA-reviewed, and operating under the narrower post-shortage pathways our legal guide tracks. The compounded discount is partly a risk premium; whether it's worth taking depends on the pharmacy behind it and your tolerance for regulatory turbulence.

Transparency

Found: Third-party-reported (verified 2026-08-05); dispensing pharmacy not publicly named. Hims & Hers: No price published (verified 2026-08-05); names its pharmacy — brand fulfillment; compounded program closed to new patients. In this market, a named pharmacy and a dated, source-verified price are worth real money — they are what let you check the claim instead of trusting it.

Commitment & cancellation

Found: none month-to-month; prepaid terms for lowest rate; membership recurs; prepaid terms are paid up front. Hims & Hers: plan recurs; plan recurs until cancelled.

Two ladders, side by side

Put both dose ladders on the same axis and the structures argue for themselves: Found holds $289 on every rung (four-month titration: exactly $1,156). A flat ladder makes dose decisions purely clinical; a scaled one attaches an invoice to every escalation — including the post-plateau bump from 10 to 12.5 mg that many patients eventually face. Full framework: the titration cost guide.

The semaglutide board

Only Found fields a verified semaglutide price here — $289/month all-in (#14 of 19) — while Hims & Hers routes semaglutide demand to brand Wegovy at $349 flat. For a buyer starting on the cheaper molecule with a likely upgrade later, single-molecule programs mean a future re-shop; dual-molecule ones price the whole arc.

The five normalizations, applied to this pair

1 · All-in, not advertised. Found's ranked figure is $289, with no membership to add; Hims & Hers bills at manufacturer/insurance rates plus any stated program fee. 2 · Maintenance basis. Found is dose-flat, so its entry and 10 mg figures coincide. 3 · Terms separated. Found: standing $289, prepaid $169 effective (12-month plan paid up front) — standing rates rank, prepaid effectives are labeled beside them. 4 · Evidence tiered. Found: third-party-reported, read 2026-08-05; Hims & Hers: no price published, read 2026-08-05. 5 · Pharmacy weighed. Found names no pharmacy; Hims & Hers names brand fulfillment; compounded program closed to new patients — in a pharmacy-variance market, disclosure is a scored asset. Run the same five on any roundup you read and most published “cheapest” lists reorder themselves.

Fine print, itemized

Found: no membership — the medication figure is the billed figure; prepaid 12-month plan paid up front at $169/mo effective; membership recurs; prepaid terms are paid up front; commitment: none month-to-month; prepaid terms for lowest rate. Hims & Hers: no membership — the medication figure is the billed figure; plan recurs until cancelled. The pattern to police on both sides is the same: memberships that outlive the medication order, renewal-relative cancellation deadlines, and prepaid terms whose refund language matters more than their discount in a year of live litigation. Cancel in writing; screenshot everything.

Transparency, audited

Found carries third-party-reported pricing (last read 2026-08-05); its dispensing pharmacy is not publicly named, so the five pharmacy questions (name, 503A/503B status, state licensure, certificate of analysis, formulation) are your pre-purchase homework. Hims & Hers carries no price published pricing (last read 2026-08-05); pharmacy disclosure is its strong suit — brand fulfillment; compounded program closed to new patients, brand fulfillment. Our weighting is unapologetic: in a market of identical molecule names, a dated source-verified price and a named pharmacy are the two claims a buyer can actually check, and they carry 25 of 100 formula points between them — the methodology shows the math, and the pharmacy guide decodes every answer the five questions can return.

Switching between them

Moving from Found to Hims & Hers (or back) is administratively unglamorous: complete the new program's intake, let its prescriber issue a fresh prescription to its pharmacy, and cancel the old subscription in writing — prescriptions don't transfer between telehealth programs, and neither do prepaid balances, which is the quiet reason month-to-month terms are worth their premium.

Refills, shipping, and the week-to-week reality

The unglamorous layer — how the medication actually reaches you and stays on schedule — splits like this: Found: shipping included; consultation included; async visit model. Hims & Hers: shipping included; consultation included in plan; async visit model. Cold-chain shipments run 3–7 days across the market; the recurring failure modes are refill-timing gaps and pharmacy backlogs, so whichever program wins here, order refills a week early and confirm the pharmacy’s current turnaround at intake.

Who should pick which

Pick Found if you want a price that survives titration; you'll prepay for the $169 effective rate; you want the insurance paperwork done for you. Pick Hims & Hers if a named pharmacy is non-negotiable for you; only the FDA-approved product will do. Neither answer is universal — which is the argument for choosing from data with dates on it rather than from whichever ad loaded first.

What verification would take

For Hims & Hers, ranking would require: any published price at all, on a page we can capture and date; the dose structure (flat or scaled, with the 10 mg tier stated); the pharmacy's name, 503A/503B status, and state licensure; commitment and cancellation terms verbatim. We publish the checklist because the gap is fixable — providers that clear it get ranked on the same arithmetic as everyone else, and readers who ask these questions get the answers this page can't yet print.

If neither one fits

The dataset's bench is deep; the closest verified third options to this matchup's price band are ShedRx at $289 (dose-scaled, no membership); OrderlyMeds at $299 (flat, no membership); SkinnyRx at $299 (flat, no membership) — or skip straight to the rankings page, where every standard “cheapest / best / no-commitment” question is answered in one sourced sentence.

The verdict

This one is a product decision more than a price decision — cheapest-possible compounded versus FDA-approved brand. Both records, with dates and sources, live in the pricing database.